Ratings Johnson Health Tech .Co., Ltd.

Equities

1736

TW0001736007

End-of-day quote Taiwan S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
82.2 TWD +1.99% Intraday chart for Johnson Health Tech .Co., Ltd. +10.34% +19.65%

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • With a 2024 P/E ratio at 24.18 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Recreational Products

1st Jan change Capi. Investor Rating ESG Refinitiv
+19.65% 763M -
+5.73% 4.04B
B+
-1.49% 3.94B
B-
+10.53% 2.92B
B+
-1.16% 1.9B
B+
+92.11% 1.23B -
-48.11% 1.16B
D
-9.30% 853M
B-
-4.80% 838M
B
+2.24% 809M -
C
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 1736 Stock
  4. Ratings Johnson Health Tech .Co., Ltd.